Metabolic Disorders clinical trials

Explore recruiting metabolic disorders clinical trials.

Recruiting metabolic disorders studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metabolic Disorders trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3 Open-Label Study of PTC923 (Sepiapterin) in Phenylketonuria

Netherlands, Germany, Spain, Italy, Denmark, Portugal +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

MULTICENTER, RANDOMIZED STUDY TO EVALUATE THE EFFICACY OF INDIVIDUALIZATION OF IMMUNOLOGICAL RISK BASED ON SELECTIVE BIOMARKERS (HLA EPLETH DISPARITY AND IFN-γ ELISPOT) TO OPTIMIZE IMMUNOSUPPRESSIVE TREATMENT IN LIVING DONOR KIDNEY TRANSPLANT PATIENTS (BIOIMMUN)

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Prospective, multicenter, randomized, open-label, parallel-group controlled phase 3 study of tacrolimus minimization in kidney transplant recipients selected according to the AGORA algorithm for their low immunological risk and medium-term graft failure

Spain, France, Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

HORNbILL. HydrOcortisone and fludRocortisoNe for critical ILLness-related corticosteroid insufficiency

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Metabolic Disorders trials by city

Metabolic Disorders clinical trials

Recruiting metabolic disorders studies right now

High-Intensity Interval Training(HIIT) on Cardio-metabolic Risk in School-age Children

GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study

A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)

Patiromer and Diet/hrQoL in Chronic Dialysis

Multi-Modal Digital Interventions for Adolescent Weight Management

Telenutrition for Individuals With SCI

Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature

Reducing Anemia Among Preconception Women in Nepal Through a Group Norm and Micronutrient Supplementation Intervention

Strong Families Start at Home/Familias Fuertes Comienzan en Casa

A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234

A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)

The Investigation of the Effectiveness of Virtual Reality Applications in Postmenopausal Osteoporosis Patients

Also recruiting in Europe

A Phase 3 Open-Label Study of PTC923 (Sepiapterin) in Phenylketonuria

MULTICENTER, RANDOMIZED STUDY TO EVALUATE THE EFFICACY OF INDIVIDUALIZATION OF IMMUNOLOGICAL RISK BASED ON SELECTIVE BIOMARKERS (HLA EPLETH DISPARITY AND IFN-γ ELISPOT) TO OPTIMIZE IMMUNOSUPPRESSIVE TREATMENT IN LIVING DONOR KIDNEY TRANSPLANT PATIENTS (BIOIMMUN)

Prospective, multicenter, randomized, open-label, parallel-group controlled phase 3 study of tacrolimus minimization in kidney transplant recipients selected according to the AGORA algorithm for their low immunological risk and medium-term graft failure

HORNbILL. HydrOcortisone and fludRocortisoNe for critical ILLness-related corticosteroid insufficiency

Metabolic Disorders trials by city

Other conditions